Form D · Biotechnology
Pegasus Biologics Inc
Irvine, CA · CIK 0001314315
Offering snapshot reported Jun 8, 2009 · SEC filing
- Reported sold
- $1.05M Offering amount: $1.05M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $608 Reported outside-investor minimum
- First sale
- May 22, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 8, 2009 | Initial | $1,047,369 | No comparison | 11 | SEC filing |
| May 15, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 16, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-72949
Source: Form D, filed Jun 8, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Trevor Moody | Director |
| Gary Restani | Director |
| Michael D Will | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 Jenner Street Suite 150
Irvine, CA, 92618
Irvine, CA, 92618